| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 10/13/2010 | EP2238988A1 Conjugated prodrugs of cc-1065 analogs |
| 10/13/2010 | EP2238144A1 Compounds comprising a cyclobutoxy group |
| 10/13/2010 | EP1204642B1 Fungicides |
| 10/13/2010 | CN201603559U 塔式连续重排反应器 Continuous rearrangement reactor tower |
| 10/13/2010 | CN101861326A Bidentate chiral ligands for use in catalytic asymmetric addition reactions |
| 10/13/2010 | CN101861305A Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis |
| 10/13/2010 | CN101861093A Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides |
| 10/13/2010 | CN101858034A Silicious organic phosphonium salt antibacterial finishing agent and preparation method and application thereof |
| 10/13/2010 | CN101857805A P-N type flame retardant and synthesis method thereof |
| 10/13/2010 | CN101857609A Phosphorus-containing compound as well as preparation method and application thereof |
| 10/13/2010 | CN101857608A Imidazole ionic liquid phosphine ligand and application of coordination compound thereof in hydroesterification |
| 10/13/2010 | CN101210031B Method for producing triphenylphosphine |
| 10/12/2010 | US7812199 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 10/12/2010 | US7812190 Forming at least two charged functional groups to provide for water-solubility and in vivo biodistribution; ionic mobility; metallization, carboxylation |
| 10/12/2010 | US7812158 Coupling agents for peptide synthesis |
| 10/12/2010 | US7812077 Polyester compositions, method of manufacture, and uses thereof |
| 10/12/2010 | CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 10/12/2010 | CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 10/07/2010 | WO2010113835A1 Method for producing imidic acid compound |
| 10/07/2010 | WO2010111737A1 Peptide and phosphopeptide synthesis via phosphate assisted ligation |
| 10/07/2010 | WO2010039543A3 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference |
| 10/07/2010 | US20100256268 Phosphorous flame retardant and application thereof to polymer |
| 10/07/2010 | US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor |
| 10/07/2010 | US20100256098 Compounds for inhibiting wip1, prodrugs and compositions thereof, and related methods |
| 10/07/2010 | US20100256097 Inhibitors of janus kinases |
| 10/07/2010 | US20100256095 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 10/07/2010 | US20100256094 Inositol pyrophosphates, and methods of use thereof |
| 10/07/2010 | US20100255521 Fluorescent substrates for Detecting organophosphatase enzyme activity |
| 10/07/2010 | US20100254931 Use of long carbon chain quaternary ammonium salt phosphoric acid ester as conditioner for hair |
| 10/07/2010 | US20100253212 Light-emission material and organic light-emitting diode including the same |
| 10/07/2010 | US20100252818 Phosphaphenanthrene compounds and organic light emitting diode using the same |
| 10/06/2010 | EP2235028A1 Process for preparing phosphonic anhydrides |
| 10/06/2010 | EP2235027A1 Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid |
| 10/06/2010 | EP2235026A1 Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a |
| 10/06/2010 | EP2234621A1 Compositions and methods for treating diseases of the nail |
| 10/06/2010 | EP2114965B1 Compounds comprising organic fluorochloro phosphate anions |
| 10/06/2010 | EP1824866B1 Method for producing onium salts comprising dialkylphosphate anions, dialkylphosphinate anions or (o-alkyl)-alkyl anions or alkyl-phosphonate anions having a low halide content |
| 10/06/2010 | EP1472188B1 Purification of onium hydroxides by electrodialysis |
| 10/06/2010 | CN1681508B Novel inhibitors of kinases |
| 10/06/2010 | CN101855015A Catalyst composition and process for oligomerization of ethylene |
| 10/06/2010 | CN101853959A Material for electrolytic solutions and use thereof |
| 10/06/2010 | CN101851254A Organophosphorus nicotinic pesticide and application thereof |
| 10/06/2010 | CN101851253A Triethylamine-free method for preparing glyphosate |
| 10/06/2010 | CN101851252A Method for preparing sodium glycerophosphate |
| 10/06/2010 | CN101177433B (s)-ornidazole disodium phosphate pentahydrate as well as preparation method and uses thereof |
| 10/06/2010 | CN101061128B Process for preparing di-isopropyl ((1(hydroxymethyl)-cyclopropyl)oxy) methylphosphonate |
| 10/05/2010 | US7807847 introducing phosphate moieties to compounds having glycerolic backbone forming 1-hexadecyl-2-(6'-carboxyethyl)hexanyl-sn-glycero-3-phosphoethanolamine; devoid of column chromatography; industrial scale; environmentally friendly |
| 10/05/2010 | US7807703 Herbicides; pesticides |
| 10/05/2010 | US7807658 Administering an optionally substituted 3-aminopropylphosphinic acid (3-amino-2-fluoropropyl)phosphinic acid, 3-amino-2-oxopropyl)phosphinic acid); irritable bowel syndrome |
| 10/05/2010 | US7807653 Nucleotide mimics and their prodrugs |
| 10/05/2010 | CA2442039C Ligands for pnicogen chelate complexes with a metal of subgroup viii and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation |
| 10/05/2010 | CA2407967C Tubulin binding ligands and corresponding prodrug constructs |
| 09/30/2010 | WO2010110684A1 Nitric oxide donors |
| 09/30/2010 | WO2010110622A2 Novel crystal forms of adefovir dipivoxil and processes for preparing the same |
| 09/30/2010 | WO2010110484A1 Onium salt with (trialkoxysilyl)alkyl group |
| 09/30/2010 | WO2010109008A1 Prodrugs of substituted 3-(4-hydroxyphenyl)-indolin-2-ones |
| 09/30/2010 | WO2010108384A1 Phosphor-nitrogen ligand derived from tetrahydroquinoline and indoline, preparation method and use thereof |
| 09/30/2010 | WO2010078449A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| 09/30/2010 | WO2009116090A3 Novel antimicrobials |
| 09/30/2010 | US20100249426 Stabilized pharmaceutical composition |
| 09/30/2010 | US20100249425 Preparation of an inorganic substrate having antimicrobial properties |
| 09/30/2010 | US20100249401 Process for the preparation of sterically hindered nitroxyl ethers |
| 09/30/2010 | US20100249393 Colorimetric-oxycarbonyl protecting groups for use in organic syntheses |
| 09/30/2010 | US20100249226 Tumor selective and biodegradable cyclotriphosphazene-platinum(ii) conjugate anticancer agent, and preparation method thereof |
| 09/30/2010 | US20100249181 HIV Protease Inhibiting Compounds |
| 09/30/2010 | US20100249074 Benzyl-cycloalkyl sphingosine 1-phosphate receptor modulators |
| 09/30/2010 | US20100249072 Prodrugs and conjugates of prenylation inhibitors |
| 09/30/2010 | US20100249071 Modulators of S1P and Methods of Making And Using |
| 09/30/2010 | US20100249068 Substituted nucleoside and nucleotide analogs |
| 09/30/2010 | US20100249067 Modulators of Mitotic Kinases |
| 09/30/2010 | US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 09/30/2010 | US20100247607 Implantable formulations of bisphosphonic acids |
| 09/30/2010 | US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use |
| 09/30/2010 | US20100247462 Synthesis of resveratrol-based natural products |
| 09/30/2010 | US20100247444 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method |
| 09/30/2010 | DE102009012640A1 Mit einer Phosphoamidatgruppe modifizierte Verbindung und deren Verwendung With a Phosphoamidatgruppe modified compound and use thereof |
| 09/29/2010 | EP2231684A1 Compounds and methods for the treatment of cancer |
| 09/29/2010 | EP2231683A1 Sulfonated organophosphine compounds and use thereof in hydroformylation processes |
| 09/29/2010 | EP2231682A1 Sulfonated organophosphine compounds and use thereof in hydroformylation processes |
| 09/29/2010 | EP2231681A1 Additive composition for ep greases with excellent antiwear and corrosion properties |
| 09/29/2010 | EP2231680A2 Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof |
| 09/29/2010 | EP1528063B1 Compound having phosphorylcholine group, polymer thereof, and process for producing the same |
| 09/29/2010 | EP1399411B1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 09/29/2010 | CN1867580B Compound modified with glycerol derivative |
| 09/29/2010 | CN101848919A Method for hydroformylation |
| 09/29/2010 | CN101848918A Mitochondrial compositions and uses thereof |
| 09/29/2010 | CN101848891A Preparation of synthetic nucleosides via [pi]-allyl transition metal complex formation |
| 09/29/2010 | CN101848710A Anthelmintic combination |
| 09/29/2010 | CN101845059A New method for preparing fosfomycin sodium for injection |
| 09/29/2010 | CN101845058A Hydroxymethylated hypophosphorous acid, derivative metal salt and preparation method thereof |
| 09/29/2010 | CN101845057A Substituted phenol for methylal phosphate anesthetic and sedative drugs and preparation method thereof |
| 09/29/2010 | CN101845009A Structural carotenoid analogs for the inhibition and amelioration of disease |
| 09/29/2010 | CN101843255A Deepen processing method of glyphosate mother liquid |
| 09/29/2010 | CN101497480B Novel industrial water treatment agent and preparation thereof |
| 09/29/2010 | CN101081854B C15phosphonate ester compound, preparation method application thereof |
| 09/29/2010 | CN101074227B Phosphine acyloxy quinazoline derivatives and their medicine uses |
| 09/28/2010 | US7803949 industrialization of effective deprotection of a tert-butyl phosphate intermediate compound without using toxic hydrogen-bsed solvents; crystallization; Lysine [(1R,2R)-2-(4-cyanophenyl)-1,3-thiazol-2-yl]-1-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-ylmethyl)propyl}-oxy]methyl dihydrogen phosphate ethan |
| 09/28/2010 | US7803886 Ligands and catalyst systems thereof for the catalytic oligomerization of olefinic monomers |
| 09/28/2010 | US7803850 Camphorquinone derivative having acylphosphine oxide group, photopolymerization initiator and photo/chemical polymerization initiator containing the same and hardenable composition containing the same |
| 09/28/2010 | US7803788 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |